The analysis of the kallikrein-related peptidase family in CRC tumor samples from The Cancer Genome Atlas (TCGA) database identified a distinct pattern of overexpression of KLK6 along with elevated expression of KLK7, KLK8, and KLK10 [18]. The gene discussed is KLK10; the disease is neoplasm.